Evidence map›Paper›PMID 29484253›Full record

ArticleBrain and behavior2018

Progressive multiple sclerosis, cognitive function, and quality of life.

Helene Højsgaard Chow, Karen Schreiber, Melinda Magyari, Cecilie Ammitzbøll, Lars Börnsen, Jeppe Romme Christensen, Rikke Ratzer, Per Soelberg Sørensen, Finn Sellebjerg

Abstract read
In one paragraph

Article in Brain and behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Influence of cognition on the correlation between objective and subjective upper limb measures in people with multiple sclerosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  15. Article
  16. Article
  17. Chitinase Signature in the Plasticity of Neurodegenerative Diseases.International journal of molecular sciences · 2023
    Review
  18. Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Helene Højsgaard ChowDepartment of Neurology Danish Multiple Sclerosis Center Rigshospitalet University of Copenhagen Copenhagen Denmark.ORCID 0000-0003-2032-2755
Karen SchreiberDepartment of Neurology Danish Multiple Sclerosis Center Rigshospitalet University of Copenhagen Copenhagen Denmark.
Melinda MagyariDepartment of Neurology Danish Multiple Sclerosis Center Rigshospitalet University of Copenhagen Copenhagen Denmark.
Cecilie AmmitzbøllDepartment of Neurology Danish Multiple Sclerosis Center Rigshospitalet University of Copenhagen Copenhagen Denmark.
Lars BörnsenDepartment of Neurology Danish Multiple Sclerosis Center Rigshospitalet University of Copenhagen Copenhagen Denmark.
Jeppe Romme ChristensenDepartment of Neurology Danish Multiple Sclerosis Center Rigshospitalet University of Copenhagen Copenhagen Denmark.
Rikke RatzerDepartment of Neurology Danish Multiple Sclerosis Center Rigshospitalet University of Copenhagen Copenhagen Denmark.
Per Soelberg SørensenDepartment of Neurology Danish Multiple Sclerosis Center Rigshospitalet University of Copenhagen Copenhagen Denmark.
Finn SellebjergDepartment of Neurology Danish Multiple Sclerosis Center Rigshospitalet University of Copenhagen Copenhagen Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with progressive multiple sclerosis (MS) often have cognitive impairment in addition to physical impairment. The burden of cognitive and physical impairment progresses over time, and may be major determinants of quality of life. The aim of this study was to assess to which degree quality of life correlates with physical and cognitive function in progressive MS. Methods: This is a retrospective study of 52 patients with primary progressive ( Results: Only measures of cognitive function correlated with the overall SF-36 quality of life score and the Mental Component Summary score from the SF-36. The only physical measure that correlated with a measure of quality of life was T25FW test, which correlated with the Physical Component Summary from the SF-36. We found no other significant correlations between the measures of cognitive function and the overall physical measures but interestingly, we found a possible relationship between the 9HPT score for the nondominant hand and the SDMT and TRAIL-B. Conclusion: Our findings support inclusion of measures of cognitive function in the assessment of patients with progressive MS as these correlated closer with quality of life than measures of physical impairment.

Indexed as

CognitionCognitive DysfunctionCost of IllnessMultiple SclerosisQuality of LifeAdultDenmarkDisability EvaluationDisease ProgressionFemaleHumansMaleMiddle AgedNeuropsychological TestsRetrospective Studiescognitive functionmultiple sclerosisphysical functionprogressive multiple sclerosisquality of life

Identifiers

PMID29484253
PMCPMC5822575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.